Liver transplantation for intrahepatic cholangiocarcinoma: ready for prime time?

G Sapisochin, T Ivanics, J Heimbach - Hepatology, 2022 - journals.lww.com
Cholangiocarcinoma (CCA) represents the second‐most common primary liver malignancy
after HCC and has risen in incidence globally in the past decades. Intrahepatic …

[HTML][HTML] Surgical treatment of intrahepatic cholangiocarcinoma: current and emerging principles

EW Beal, JM Cloyd, TM Pawlik - Journal of Clinical Medicine, 2020 - mdpi.com
Intrahepatic cholangiocarcinoma (ICC) is a rare, aggressive cancer of the biliary tract. It often
presents with locally advanced or metastatic disease, but for patients with early-stage …

[HTML][HTML] Liver transplantation in the management of cholangiocarcinoma: Evolution and contemporary advances

A Borakati, F Froghi, RH Bhogal… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Cholangiocarcinoma (CCA) is an aggressive malignancy arising from the biliary epithelium.
It may occur at any location along the biliary tree with the perihilar area being the most …

[HTML][HTML] Multidisciplinary treatment for hilar and intrahepatic cholangiocarcinoma: A review of the general principles

G Sapisochin, T Ivanics, V Subramanian… - International Journal of …, 2020 - Elsevier
Cholangiocarcinoma (CCA) is a rare but devastating malignancy that presents late, and
associated with a high mortality if untreated. CCA is locally aggressive and located in close …

A systematic review and meta‐analysis of pathologic complete response rates for patients with cholangiocarcinoma treated on liver transplant protocols

TC Wu, CP Smith, JS Li, J Burton… - Journal of surgical …, 2024 - Wiley Online Library
Abstract Background and Objectives Many heterogenous orthotopic liver transplant (OLT)
protocols exist for patients with unresectable cholangiocarcinoma. Little is known about the …

[HTML][HTML] Incidence trend and competing risk analysis of patients with intrahepatic cholangiocarcinoma: A population-based study

H Xing, B Tan, C Yang, M Zhang - Frontiers in Medicine, 2022 - frontiersin.org
Background: Intrahepatic cholangiocarcinoma (ICCA) is a primary liver cancer characterized
by rapid progression and poor prognosis. There are few effective tools for evaluating the …

[HTML][HTML] Stereotactic radiotherapy for intrahepatic cholangiocarcinoma

A Borakati, F Froghi, RH Bhogal… - World Journal of …, 2022 - ncbi.nlm.nih.gov
Intrahepatic cholangiocarcinoma (iCCA) is an aggressive malignancy with an increasing
incidence worldwide and poor prognosis, despite several advances and continuous efforts …

[HTML][HTML] Liver transplantation in malignant disease

SA Lang, J Bednarsch, Z Czigany… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Liver transplantation for malignant disease has gained increasing attention as part of
transplant oncology. Following the implementation of the Milan criteria, hepatocellular …

Liver transplantation for cholangiocarcinoma: insights into the prognosis and the evolving indications

GG Panayotova, F Paterno, JV Guarrera… - Current oncology …, 2020 - Springer
Abstract Purpose of Review Cholangiocarcinoma (CCA) is a rare malignancy of the biliary
ducts that can be classified as intrahepatic, perihilar, or distal based on anatomic location …

[HTML][HTML] Cholangiocarcinoma as an indication for liver transplantation in the era of transplant oncology

E Gringeri, M Gambato, G Sapisochin, T Ivanics… - Journal of Clinical …, 2020 - mdpi.com
Cholangiocarcinoma (CCA) arises from the biliary tract epithelium and accounts for 10–15%
of all hepatobiliary malignancies. Depending on anatomic location, CCA is classified as …